Table 1.
Washington State Medicaid OUD population and MOUD average monthly utilization rates for three-month rolling averages.
| OUD Population | Hub and Spoke | Non-Hub and Spoke | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pre-Period | Post-Period | Pre-Period | Post-Period | Pre-Period | Post-Period | ||||||||
| Model | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | |
| Rate* | Monthly OUD Population | 28030 | 1618 | 32982 | 1794 | 1243 | 147 | 2547 | 606 | 26787 | 1472 | 30435 | 1212 |
| Any MOUD | 39.73 | 1.72 | 50.49 | 3.77 | 39.71 | 2.42 | 60.27 | 9.12 | 39.73 | 1.70 | 49.59 | 3.25 | |
| Buprenorp hine | 13.36 | 2.04 | 24.68 | 4.46 | 16.30 | 2.49 | 35.86 | 8.01 | 13.23 | 2.01 | 23.70 | 4.04 | |
| Methadone | 25.90 | 0.89 | 24.60 | 1.29 | 22.38 | 0.70 | 21.54 | 1.45 | 26.06 | 0.91 | 24.82 | 1.41 | |
| Naltrexone | 0.54 | 0.23 | 1.37 | 0.17 | 1.13 | 0.58 | 3.33 | 0.64 | 0.51 | 0.21 | 1.21 | 0.13 | |
Notes.
=3 month rolling average MOUD Utilization SD= Standard Deviation. Pre-Period= January 01, 2016 – June 30, 2017, Post-Period= July 01, 2017 – June 30, 2019. Any MOUD includes buprenorphine, methadone, and naltrexone.